Profile picture

Professor Denise Hilfiker-Kleiner

Hannover Medical School, Hannover (Germany)
Follow
Biography
Denise Hilfiker-Kleiner received her PhD in 1994 at the University of Zurich and Emory University, Atlanta and her habilitation 2006 at Hannover Medical School (MHH). She has a longstanding experience in analyzing genetic and epigenetic mechanisms, signaling modules and cell to cell communication in the cardiovascular system relevant for cardiac physiological and pathophysiological processes. Her research focus is on heart failure specifically in the context of pregnancy and cancer in relation to degneration and regeneration. Her work has been published in top-ranked journals, i.e. Cell, Nature, JCI, EHJ, EMBO, Circulation and many others. From 2008-2020 she was professor for Molecular Cardiology and from 2013-2020 dean of research of the MHH. Since 2021 she is dean of the medical faculty and professor for side of effects of cancer therapies at the Philipps University, Marburg (G). Since 2018 she is a member of the German Research Council.
Logo ESC

Contributor content

Heart failure: a disease of the blood or blood vessels?
Session
Heart failure: a disease of the blood or blood vessels?
28 August 2021
Peripartum cardiomyopathy
Session
Peripartum cardiomyopathy
29 June 2021
Off the record with Professor Dirk Brutsaert
Session
Off the record with Professor Dirk Brutsaert
27 May 2019
Late Breaking Basic and Translational Science - Cardiac Biology
Session
Late Breaking Basic and Translational Science - Cardiac Biology
28 August 2018
T cells, autoimmunity and myocardial disease
Session
T cells, autoimmunity and myocardial disease
28 August 2018
Precision medicine: The critical roles for big data and machine learning
Session
Precision medicine: The critical roles for big data and machine learning
27 August 2018
New strategies for diagnosis and treatment in dilated cardiomyopathy
Session
New strategies for diagnosis and treatment in dilated cardiomyopathy
26 August 2018
Mechanisms of Heart Failure with preserved Ejection Fraction - Implications for treatment
Session
Mechanisms of Heart Failure with preserved Ejection Fraction - Implications for treatment
28 August 2017
Genetics and gene therapy in cardiovascular diseases
Session
Genetics and gene therapy in cardiovascular diseases
28 August 2017
Cardiac degeneration and senescence
Session
Cardiac degeneration and senescence
28 August 2017

ESC 365 is supported by